DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Agarwals Eye Hospital filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2025 with BSE, as required under SEBI LODR Regulation 24-A. The Practising Company Secretary confirmed overall compliance with SEBI regulations, recording NIL observations on most parameters including secretarial standards, policies, website disclosures, director qualifications, and related-party transactions. A previous non-compliance regarding 100% dematerialization of promoter shareholding (Regulation 31(2)) was fully rectified by April 30, 2024, when 6,700 promoter group shares were converted to demat form. BSE levied a fine of Rs. 4.42 lakh plus 18% GST on November 21, 2024 for an alleged non-compliance over constitution of the Audit, Nomination & Remuneration, and Stakeholders Relationship Committees, which the company has contested and submitted a waiver application for. One minor delay in reporting GST penalty orders under Regulation 30 was also noted.
This is a routine annual compliance submission with no material business impact. The pending Rs. 4.42 lakh BSE fine is a small amount and the company is actively contesting it; investors should watch for the waiver outcome.